| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.8M | — | -29.7% |
| R&D Expense | $170K | — | -30.6% |
| SG&A Expense | $22.6M | — | +5.2% |
| Operating Income | -$18.5M | — | -54.7% |
| Interest Expense | $3.9M | — | +17.6% |
| Pre-tax Income | -$29.7M | — | -132.1% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$29.7M | — | -131.5% |
| EPS (Basic) | -$0.82 | — | -95.2% |
| EPS (Diluted) | -$0.82 | — | -95.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $39.4M | -7.2% | +89.8% |
| Short-term Investments | $76.1M | -7.2% | +38.2% |
| Accounts Receivable | $24.6M | -27.9% | +210.5% |
| Inventory | $6.2M | +0.0% | — |
| Current Assets | $185.3M | -10.4% | +52.7% |
| Total Assets | $371.7M | -3.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | -108.6% |
| Investing Cash Flow | -$9.3M | — | +61.3% |
| Financing Cash Flow | $9.5M | — | +116.0% |
| +30.5% |
| Current Liabilities | $53.6M | -9.9% | +67.4% |
| Long-term Debt | $202.7M | +0.8% | +75.7% |
| Total Liabilities | $290.9M | -0.1% | +48.4% |
| Stockholders' Equity | $80.8M | -14.8% | -9.1% |